Pharmaceutical Pricing and Reimbursement Policies in Canada:
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada's achievements in meeting a range of objectiv...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Electronic eBook |
Language: | English |
Published: |
Paris
OECD Publishing
2006
|
Series: | OECD Health Working Papers
|
Subjects: | |
Links: | https://doi.org/10.1787/346071162287 |
Summary: | This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada's achievements in meeting a range of objectives relating to the pharmaceutical policy. The federal government regulates prices of patented pharmaceutical products with the objective of protecting consumers against excessive prices. Regulation has very likely been responsible for bringing Canada's prices for patented medicines roughly in line with European comparators. Prices of generic products, which are not regulated, are relatively high although high... |
Physical Description: | 1 Online-Ressource (90 Seiten) 21 x 29.7cm |
DOI: | 10.1787/346071162287 |
Staff View
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV047931732 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 220413s2006 xx o|||| 00||| eng d | ||
024 | 7 | |a 10.1787/346071162287 |2 doi | |
035 | |a (ZDB-13-SOC)061316555 | ||
035 | |a (OCoLC)1312690674 | ||
035 | |a (DE-599)BVBBV047931732 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-384 |a DE-91 |a DE-473 |a DE-824 |a DE-29 |a DE-739 |a DE-355 |a DE-20 |a DE-1028 |a DE-1049 |a DE-188 |a DE-521 |a DE-861 |a DE-898 |a DE-92 |a DE-573 |a DE-19 | ||
100 | 1 | |a Paris, Valérie |e Verfasser |4 aut | |
245 | 1 | 0 | |a Pharmaceutical Pricing and Reimbursement Policies in Canada |c Valérie Paris and Elizabeth Docteur |
264 | 1 | |a Paris |b OECD Publishing |c 2006 | |
300 | |a 1 Online-Ressource (90 Seiten) |c 21 x 29.7cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a OECD Health Working Papers | |
520 | |a This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada's achievements in meeting a range of objectives relating to the pharmaceutical policy. The federal government regulates prices of patented pharmaceutical products with the objective of protecting consumers against excessive prices. Regulation has very likely been responsible for bringing Canada's prices for patented medicines roughly in line with European comparators. Prices of generic products, which are not regulated, are relatively high although high... | ||
650 | 4 | |a Social Issues/Migration/Health | |
650 | 4 | |a Canada | |
700 | 1 | |a Docteur, Elizabeth |4 ctb | |
856 | 4 | 0 | |u https://doi.org/10.1787/346071162287 |x Verlag |z kostenfrei |3 Volltext |
912 | |a ZDB-13-SOC | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033313225 |
Record in the Search Index
DE-BY-OTHR_katkey | 6531092 |
---|---|
DE-BY-TUM_katkey | 2628094 |
_version_ | 1831257600897843200 |
adam_text | |
any_adam_object | |
author | Paris, Valérie |
author2 | Docteur, Elizabeth |
author2_role | ctb |
author2_variant | e d ed |
author_facet | Paris, Valérie Docteur, Elizabeth |
author_role | aut |
author_sort | Paris, Valérie |
author_variant | v p vp |
building | Verbundindex |
bvnumber | BV047931732 |
collection | ZDB-13-SOC |
ctrlnum | (ZDB-13-SOC)061316555 (OCoLC)1312690674 (DE-599)BVBBV047931732 |
discipline | Wirtschaftswissenschaften |
doi_str_mv | 10.1787/346071162287 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV047931732</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220413s2006 xx o|||| 00||| eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/346071162287</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-13-SOC)061316555</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1312690674</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047931732</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-861</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Paris, Valérie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Pricing and Reimbursement Policies in Canada</subfield><subfield code="c">Valérie Paris and Elizabeth Docteur</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (90 Seiten)</subfield><subfield code="c">21 x 29.7cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Health Working Papers</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada's achievements in meeting a range of objectives relating to the pharmaceutical policy. The federal government regulates prices of patented pharmaceutical products with the objective of protecting consumers against excessive prices. Regulation has very likely been responsible for bringing Canada's prices for patented medicines roughly in line with European comparators. Prices of generic products, which are not regulated, are relatively high although high...</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Canada</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Docteur, Elizabeth</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1787/346071162287</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033313225</subfield></datafield></record></collection> |
id | DE-604.BV047931732 |
illustrated | Not Illustrated |
indexdate | 2025-01-11T15:45:31Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033313225 |
oclc_num | 1312690674 |
open_access_boolean | 1 |
owner | DE-384 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-188 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-573 DE-19 DE-BY-UBM |
owner_facet | DE-384 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-188 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-573 DE-19 DE-BY-UBM |
physical | 1 Online-Ressource (90 Seiten) 21 x 29.7cm |
psigel | ZDB-13-SOC |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | OECD Publishing |
record_format | marc |
series2 | OECD Health Working Papers |
spellingShingle | Paris, Valérie Pharmaceutical Pricing and Reimbursement Policies in Canada Social Issues/Migration/Health Canada |
title | Pharmaceutical Pricing and Reimbursement Policies in Canada |
title_auth | Pharmaceutical Pricing and Reimbursement Policies in Canada |
title_exact_search | Pharmaceutical Pricing and Reimbursement Policies in Canada |
title_full | Pharmaceutical Pricing and Reimbursement Policies in Canada Valérie Paris and Elizabeth Docteur |
title_fullStr | Pharmaceutical Pricing and Reimbursement Policies in Canada Valérie Paris and Elizabeth Docteur |
title_full_unstemmed | Pharmaceutical Pricing and Reimbursement Policies in Canada Valérie Paris and Elizabeth Docteur |
title_short | Pharmaceutical Pricing and Reimbursement Policies in Canada |
title_sort | pharmaceutical pricing and reimbursement policies in canada |
topic | Social Issues/Migration/Health Canada |
topic_facet | Social Issues/Migration/Health Canada |
url | https://doi.org/10.1787/346071162287 |
work_keys_str_mv | AT parisvalerie pharmaceuticalpricingandreimbursementpoliciesincanada AT docteurelizabeth pharmaceuticalpricingandreimbursementpoliciesincanada |